← Back to Search

Rebreathing for Hypoxia Effects on Glucose Levels

N/A

Recruiting

Led By Sophie Lalande

Research Sponsored by University of Texas at Austin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up collected at min 0, 30, 60, 90 and 120 minutes of the oral glucose tolerance test

Awards & highlights

Study Summary

This trial will study the effects of holding one's breath on blood sugar levels in people with and without diabetes.

Who is the study for?

This trial is for men and women aged 18 to 80 who are healthy, prediabetic, or have type 2 diabetes but not on insulin or multiple blood pressure meds. Smokers, pregnant individuals, those with lung diseases, uncontrolled high blood pressure, heart disease history or diabetic complications cannot participate.Check my eligibility

What is being tested?

The study tests how holding one's breath (rebreathing-induced hypoxia) affects blood sugar levels during a glucose tolerance test in different groups: healthy people, those with prediabetes and type 2 diabetics.See study design

What are the potential side effects?

Potential side effects may include discomfort from holding breath repeatedly and the stress of undergoing an oral glucose tolerance test. Specific risks will depend on individual health status.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected at min 0, 30, 60, 90 and 120 minutes of the oral glucose tolerance test

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected at min 0, 30, 60, 90 and 120 minutes of the oral glucose tolerance test

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at min 0, 30, 60, 90 and 120 minutes of the oral glucose tolerance test for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in plasma glucose levels

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Rebreathing-induced hypoxiaExperimental Treatment1 Intervention

Participants will rebreathe room air from a low-volume closed-circuit system for a period of 2 minutes.

Group II: Spontaneous breathingPlacebo Group1 Intervention

Participants will be spontaneously breathing during an oral glucose tolerance test.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor

353 Previous Clinical Trials

81,214 Total Patients Enrolled

Sophie LalandePrincipal InvestigatorUT Austin

1 Previous Clinical Trials

41 Total Patients Enrolled

Media Library

Rebreathing-induced hypoxia Clinical Trial Eligibility Overview. Trial Name: NCT05422430 — N/A

Low Oxygen Levels Research Study Groups: Spontaneous breathing, Rebreathing-induced hypoxia

Low Oxygen Levels Clinical Trial 2023: Rebreathing-induced hypoxia Highlights & Side Effects. Trial Name: NCT05422430 — N/A

Rebreathing-induced hypoxia 2023 Treatment Timeline for Medical Study. Trial Name: NCT05422430 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project still recruiting participants?

"Affirmative. According to the details posted on clinicaltrials.gov, this medical trial is still recruiting participants with the first post being made October 21st 2021 and recent updates provided in June 13th 2022. A total of 30 individuals will be recruited at one particular site."

Answered by AI

Are there certain criteria that must be fulfilled in order to participate in this clinical trial?

"This medical study is accepting 30 individuals, aged 18 to 80, who are suffering from hypoxemia. To be eligible for the trial applicants must meet all of these qualifications: both genders between 18 and 80 years old."

Answered by AI

Are individuals younger than forty being included in this clinical research?

"This clinical trial is open to applicants aged 18-80. There are a total of 37 studies for minors and 103 studies specifically designed for seniors."

Answered by AI

To what extent is participation in this research endeavor being taken up?

"Confirmed. The clinical trial registry on clinicialtrials.gov reveals that this medical research is currently searching for participants, having been initially posted in October 2021 and most recently updated in June 2022. 30 individuals must be recruited from a single site to complete the study's requirements."

Answered by AI